Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hamouda

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 13, 2008
[HIV, HCV, HBV and syphilis infections among blood donors in Germany 2006. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act]Levke Willand, S Ritter, B Reinhard, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 13, 2008
[Demography and donation frequencies of blood and plasma donor populations in Germany]Sabine Ritter, L Willand, B Reinhard, et al.
Archives of Dermatology|August 1, 1993
Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in GermanyB Rzany, M Mockenhaupt, U Stocker, et al.
Vox Sanguinis|October 22, 2014
Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in GermanyM an der Heiden, S Ritter, O Hamouda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2005
Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998W Hellenbrand, W Thierfelder, B Müller-Pebody, et al.
European Journal of Medical Research|June 23, 2009
Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating diseaseU Kastenbauer, E Wolf, C Kollan, et al.
Deutsche Medizinische Wochenschrift (1946)|June 2, 2010
[Long-term efficacy of second-line treatment of HIV infection after class change following virological failure on protease inhibitor-based therapy]J Brunner, U Seybold, B Gunsenheimer-Bartmeyer, et al.
AIDS (London, England)|April 11, 1992
Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991B Schwartländer, C R Horsburgh, O Hamouda, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 31, 2013
Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006K Haar, V Bremer, C Houareau, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 9, 2013
An assessment of the current Chlamydia trachomatis laboratory practices in GermanyD Schmidt, H Päschke, V Bremer, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 13, 2008
[HIV, HCV, HBV and syphilis infections among blood donors in Germany 2006. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act]Levke Willand, S Ritter, B Reinhard, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 13, 2008
[Demography and donation frequencies of blood and plasma donor populations in Germany]Sabine Ritter, L Willand, B Reinhard, et al.
Archives of Dermatology|August 1, 1993
Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in GermanyB Rzany, M Mockenhaupt, U Stocker, et al.
Vox Sanguinis|October 22, 2014
Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in GermanyM an der Heiden, S Ritter, O Hamouda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2005
Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998W Hellenbrand, W Thierfelder, B Müller-Pebody, et al.
European Journal of Medical Research|June 23, 2009
Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating diseaseU Kastenbauer, E Wolf, C Kollan, et al.
Deutsche Medizinische Wochenschrift (1946)|June 2, 2010
[Long-term efficacy of second-line treatment of HIV infection after class change following virological failure on protease inhibitor-based therapy]J Brunner, U Seybold, B Gunsenheimer-Bartmeyer, et al.
AIDS (London, England)|April 11, 1992
Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991B Schwartländer, C R Horsburgh, O Hamouda, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 31, 2013
Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006K Haar, V Bremer, C Houareau, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 9, 2013
An assessment of the current Chlamydia trachomatis laboratory practices in GermanyD Schmidt, H Päschke, V Bremer, et al.
Pageof 9